Chewing bitter kola will decrease intraocular pressure in the eyes of healthy young adults by 21 per cent and this may be beneficial to persons with primary open-angle glaucoma (POAG), which is a very normal form of glaucoma or ocular hypertension in low-income settings, a study has proven. This post talks more about how to lower eye pressure by eating bitter-kola
In recent study, researchers evaluated the consequence of consuming bitter kola on intraocular pressure (IOP) in 46 healthy individuals aged between 19 and 27 years at the Optometry Clinic of the University of Cape Coast, Ghana. They were enlisted from the University of Cape Coast student population and shared into two teams (A and B).
Team A carried 100 mg/kg body weight of bitter kola that was crushed and melted in a 200 ml of water on their first arrival and Team B swallowed 200 ml of water. On the next arrival, the directive of treatment was switched. The IOP was measured at starting point and each 45 minutes intermission for 135 minutes.
How To Lower Eye Pressure By Eating Bitter-Kola
The dose of 100 mg/kg taken in this research is equal to 5.0 to 9.6 grams of bitter kola and it drops in the regular ingestion of two nuts of bitter kola. This dose is considered to be harmless because other scientists had speculated that high doses (400 mg/kg) of bitter kola can be poisonous to human body part and may result to liver damage and peptic ulcer.
They had a starting position IOP scale of between 11 and 24 mmHg on both eyes, and not any of the matters was a spontaneous or usual bitter kola eater. Also, individuals with a family history of glaucoma, any eye or systemic disease, or were taking any forms of medication at the time of the study were excluded from participating in the study.
Also, families who had account of glaucoma, any eye or general illness or were receiving any form of treatment at the time of the study although omitted, were personalities that had reported sensitive responses to bitter kola, corneal irregularities or have possible risk factors for angle-closure glaucoma.
In 2020 research to determine if eating bitter kola in a dose compared to normal daily eating rate will reduce IOP particularly in healthy young adults. They discovered that the average IOP capacities reduced by 7.9, 18.2 and 20.6 percent at 45, 90 and 135 minutes, correspondingly, after bitter kola treatment.
The reduction however flexible across the individuals was statistically important through the separate time points. Glaucoma is the major cause of permanent sightlessness globally. Its most common form primary open-angle glaucoma (POAG) is featured by progressive optic nerve deterioration and has an emotional impact on more than 60 million persons globally.
In Africa, glaucoma accounts for 15 per cent of sightlessness and it is the area with the maximum occurrence of sightlessness compared to other areas universally. Intraocular pressure is the only adjustable factor in patients with glaucoma; therefore, management with IOP-lowering medication has been serious to stop loss of sight.
Nevertheless, the growth of a lively natural produce that is real in lowering IOP and have little side effects that may be critical in improving glaucoma management compliance. One of such natural produce is bitter kola. It is known as ‘bitter kola’ because of its classic diverse bitter flavor.
In Africa, bitter kola is generally used for traditional welcome and functions different roles in the management of numerous sicknesses comprising coughs, colds, voice hoarseness, aphrodisiac and liver diseases. Studies have discovered that Bitter kola has blood pressure dropping effects.
It has also revealed possible usefulness for fighting infectious illnesses, including Ebola, by pausing viral duplication. Also, there is a vital scientific proof signifying that bitter kola is harmless in individuals at the average intake level. The IOP-lowering effect of smearing its water solution has been proven in both animal and mortal studies, together with a new randomized clinical trial which inspected various IOP-lowering medications.